Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle maturation (GO:0016188) | 6.49234258 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.32393192 |
3 | locomotory exploration behavior (GO:0035641) | 6.31112695 |
4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.99004470 |
5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.59684992 |
6 | synaptic vesicle exocytosis (GO:0016079) | 5.58039417 |
7 | glutamate secretion (GO:0014047) | 5.42170291 |
8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.41489796 |
9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.32052445 |
10 | vocalization behavior (GO:0071625) | 5.22641999 |
11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.14976812 |
12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.12823678 |
13 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 5.09905995 |
14 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.95547481 |
15 | exploration behavior (GO:0035640) | 4.90910528 |
16 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.90482181 |
17 | regulation of synapse structural plasticity (GO:0051823) | 4.83111853 |
18 | layer formation in cerebral cortex (GO:0021819) | 4.82398207 |
19 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.74766359 |
20 | nuclear pore complex assembly (GO:0051292) | 4.70765259 |
21 | protein localization to synapse (GO:0035418) | 4.66435982 |
22 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.62939432 |
23 | regulation of synaptic vesicle transport (GO:1902803) | 4.54660351 |
24 | neurotransmitter secretion (GO:0007269) | 4.39260834 |
25 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.29507180 |
26 | dendritic spine morphogenesis (GO:0060997) | 4.23937320 |
27 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.14974310 |
28 | neuronal action potential propagation (GO:0019227) | 4.12798442 |
29 | synaptic transmission, glutamatergic (GO:0035249) | 4.08774175 |
30 | glutamate receptor signaling pathway (GO:0007215) | 4.06412120 |
31 | long-term memory (GO:0007616) | 3.99928729 |
32 | activation of protein kinase A activity (GO:0034199) | 3.99743366 |
33 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.99677447 |
34 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.99286840 |
35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.97258544 |
36 | positive regulation of synapse maturation (GO:0090129) | 3.94874840 |
37 | proline transport (GO:0015824) | 3.93088632 |
38 | cellular potassium ion homeostasis (GO:0030007) | 3.91949739 |
39 | neuron-neuron synaptic transmission (GO:0007270) | 3.91822320 |
40 | neuron cell-cell adhesion (GO:0007158) | 3.89368114 |
41 | regulation of synaptic plasticity (GO:0048167) | 3.88897171 |
42 | positive regulation of membrane potential (GO:0045838) | 3.88076388 |
43 | regulation of beta-amyloid formation (GO:1902003) | 3.83142804 |
44 | sodium ion export (GO:0071436) | 3.82865717 |
45 | nuclear pore organization (GO:0006999) | 3.82233182 |
46 | neuromuscular process controlling balance (GO:0050885) | 3.81691170 |
47 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.77379425 |
48 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.73928405 |
49 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.73212737 |
50 | regulation of postsynaptic membrane potential (GO:0060078) | 3.72562597 |
51 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.68759802 |
52 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.59783777 |
53 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.59461773 |
54 | long-term synaptic potentiation (GO:0060291) | 3.57439574 |
55 | detection of molecule of bacterial origin (GO:0032490) | 3.55814383 |
56 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.53417203 |
57 | vesicle transport along microtubule (GO:0047496) | 3.51934374 |
58 | gamma-aminobutyric acid transport (GO:0015812) | 3.48489930 |
59 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.46606772 |
60 | dendritic spine organization (GO:0097061) | 3.45816941 |
61 | cerebellar granule cell differentiation (GO:0021707) | 3.45714901 |
62 | regulation of dendritic spine development (GO:0060998) | 3.44191419 |
63 | prepulse inhibition (GO:0060134) | 3.42362987 |
64 | behavioral fear response (GO:0001662) | 3.40600491 |
65 | behavioral defense response (GO:0002209) | 3.40600491 |
66 | neurotransmitter transport (GO:0006836) | 3.32896466 |
67 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.31902987 |
68 | neuron recognition (GO:0008038) | 3.31690785 |
69 | synaptic vesicle endocytosis (GO:0048488) | 3.31159668 |
70 | pore complex assembly (GO:0046931) | 3.30722772 |
71 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.30558996 |
72 | L-amino acid import (GO:0043092) | 3.30508021 |
73 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.29983319 |
74 | positive regulation of neurotransmitter transport (GO:0051590) | 3.29855359 |
75 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.27501505 |
76 | regulation of neurotransmitter secretion (GO:0046928) | 3.27166784 |
77 | innervation (GO:0060384) | 3.25276706 |
78 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.24539037 |
79 | response to histamine (GO:0034776) | 3.24379920 |
80 | auditory behavior (GO:0031223) | 3.23349850 |
81 | positive regulation of dendritic spine development (GO:0060999) | 3.21944780 |
82 | regulation of vesicle fusion (GO:0031338) | 3.21228112 |
83 | * peptidyl-threonine phosphorylation (GO:0018107) | 3.20940785 |
84 | regulation of histone H3-K27 methylation (GO:0061085) | 3.20895298 |
85 | dendrite morphogenesis (GO:0048813) | 3.20671650 |
86 | cellular extravasation (GO:0045123) | 3.19975459 |
87 | axonal fasciculation (GO:0007413) | 3.19183252 |
88 | cell communication by electrical coupling (GO:0010644) | 3.18951798 |
89 | regulation of ARF protein signal transduction (GO:0032012) | 3.18806979 |
90 | iron ion import (GO:0097286) | 3.15676655 |
91 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.15185959 |
92 | fear response (GO:0042596) | 3.14232802 |
93 | establishment of nucleus localization (GO:0040023) | 3.13279684 |
94 | regulation of neurotransmitter levels (GO:0001505) | 3.13194913 |
95 | transmission of nerve impulse (GO:0019226) | 3.09858037 |
96 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.06000012 |
97 | regulation of RNA export from nucleus (GO:0046831) | 3.05747670 |
98 | regulation of cellular amide metabolic process (GO:0034248) | 3.05645356 |
99 | regulation of neurotransmitter transport (GO:0051588) | 3.03693669 |
100 | organelle transport along microtubule (GO:0072384) | 3.03555228 |
101 | positive regulation of fibroblast migration (GO:0010763) | 3.03257677 |
102 | gas transport (GO:0015669) | 3.02893832 |
103 | learning (GO:0007612) | 3.02485192 |
104 | * peptidyl-threonine modification (GO:0018210) | 3.02296688 |
105 | protein localization to endosome (GO:0036010) | 3.01957157 |
106 | response to auditory stimulus (GO:0010996) | 3.01852524 |
107 | membrane depolarization (GO:0051899) | 3.00746731 |
108 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.00601623 |
109 | positive regulation of synaptic transmission (GO:0050806) | 3.00511073 |
110 | neuromuscular process (GO:0050905) | 2.99901852 |
111 | long term synaptic depression (GO:0060292) | 2.97536830 |
112 | negative regulation of cell killing (GO:0031342) | 2.96889774 |
113 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.96889774 |
114 | hypotonic response (GO:0006971) | 2.96831356 |
115 | social behavior (GO:0035176) | 2.96739568 |
116 | intraspecies interaction between organisms (GO:0051703) | 2.96739568 |
117 | regulation of synaptic transmission (GO:0050804) | 2.96259246 |
118 | dopamine receptor signaling pathway (GO:0007212) | 2.96178483 |
119 | regulation of female receptivity (GO:0045924) | 2.94056899 |
120 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.93580614 |
121 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.92051583 |
122 | chemosensory behavior (GO:0007635) | 2.90033721 |
123 | clathrin coat assembly (GO:0048268) | 2.88521637 |
124 | glycine transport (GO:0015816) | 2.86805842 |
125 | amino acid import (GO:0043090) | 2.86709264 |
126 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.85804878 |
127 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.85804878 |
128 | modulation by symbiont of host immune response (GO:0052553) | 2.85804878 |
129 | positive regulation by symbiont of host defense response (GO:0052509) | 2.85804878 |
130 | modulation by symbiont of host defense response (GO:0052031) | 2.85804878 |
131 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.85804878 |
132 | neuronal ion channel clustering (GO:0045161) | 2.85622861 |
133 | histone H3-K9 demethylation (GO:0033169) | 2.85483114 |
134 | membrane depolarization during action potential (GO:0086010) | 2.83242687 |
135 | import into cell (GO:0098657) | 2.79822486 |
136 | oxygen transport (GO:0015671) | 2.77098684 |
137 | positive regulation of Rap GTPase activity (GO:0032854) | 2.76994955 |
138 | cortical actin cytoskeleton organization (GO:0030866) | 2.75155075 |
139 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.74403487 |
140 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.73922035 |
141 | definitive hemopoiesis (GO:0060216) | 2.72198137 |
142 | potassium ion homeostasis (GO:0055075) | 2.71620473 |
143 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.70768476 |
144 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.69423804 |
145 | macrophage activation involved in immune response (GO:0002281) | 2.68213551 |
146 | vesicle coating (GO:0006901) | 2.66928289 |
147 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.66730184 |
148 | nerve growth factor signaling pathway (GO:0038180) | 2.61274984 |
149 | protein export from nucleus (GO:0006611) | 2.58301282 |
150 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.57314954 |
151 | positive regulation of receptor recycling (GO:0001921) | 2.56670813 |
152 | positive regulation of protein dephosphorylation (GO:0035307) | 2.56471129 |
153 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.55744599 |
154 | detection of external biotic stimulus (GO:0098581) | 2.53977123 |
155 | regulation of regulated secretory pathway (GO:1903305) | 2.51338685 |
156 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.49345210 |
157 | COPI coating of Golgi vesicle (GO:0048205) | 2.49206962 |
158 | Golgi transport vesicle coating (GO:0048200) | 2.49206962 |
159 | regulation of leukocyte degranulation (GO:0043300) | 2.48486548 |
160 | embryonic process involved in female pregnancy (GO:0060136) | 2.48333141 |
161 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.45903074 |
162 | corticosteroid receptor signaling pathway (GO:0031958) | 2.44974388 |
163 | cell-substrate adherens junction assembly (GO:0007045) | 2.43925170 |
164 | focal adhesion assembly (GO:0048041) | 2.43925170 |
165 | potassium ion import (GO:0010107) | 2.43019290 |
166 | regulation of ARF GTPase activity (GO:0032312) | 2.41345871 |
167 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.40745073 |
168 | myeloid cell development (GO:0061515) | 2.37909253 |
169 | regulation of Rap GTPase activity (GO:0032317) | 2.37808264 |
170 | megakaryocyte development (GO:0035855) | 2.37122508 |
171 | cellular response to catecholamine stimulus (GO:0071870) | 2.36101452 |
172 | cellular response to monoamine stimulus (GO:0071868) | 2.36101452 |
173 | cortical cytoskeleton organization (GO:0030865) | 2.35510064 |
174 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.35296636 |
175 | regulation of Rac protein signal transduction (GO:0035020) | 2.31912639 |
176 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.31386971 |
177 | regulation of gamma-delta T cell activation (GO:0046643) | 2.31033269 |
178 | erythrocyte development (GO:0048821) | 2.30345386 |
179 | positive regulation of regulated secretory pathway (GO:1903307) | 2.29748801 |
180 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.29387652 |
181 | phosphatidylinositol phosphorylation (GO:0046854) | 2.26122376 |
182 | histone H3-K36 demethylation (GO:0070544) | 2.25474873 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.23993141 |
2 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.56748316 |
3 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.47267227 |
4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.06702287 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.01469049 |
6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.01176675 |
7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.92834045 |
8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.86633092 |
9 | GATA1_19941826_ChIP-Seq_K562_Human | 2.80318173 |
10 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.74785048 |
11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.72745255 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.69953971 |
13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69942142 |
14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69942142 |
15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54864222 |
16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54734536 |
17 | SPI1_23127762_ChIP-Seq_K562_Human | 2.54421593 |
18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.52026457 |
19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.51292921 |
20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.47204017 |
21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.47092493 |
22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.44571214 |
23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.40292105 |
24 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.37415643 |
25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.35081304 |
26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.29437303 |
27 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.25771653 |
28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.22504870 |
29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.20372742 |
30 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.19060499 |
31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.15692099 |
32 | GATA2_19941826_ChIP-Seq_K562_Human | 2.15223654 |
33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13092359 |
34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13090716 |
35 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.09769822 |
36 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.05729123 |
37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.05036476 |
38 | MYC_22102868_ChIP-Seq_BL_Human | 2.04216843 |
39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03117455 |
40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.02583004 |
41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02304049 |
42 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.98636762 |
43 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.98279456 |
44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93248864 |
45 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.90684344 |
46 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83575372 |
47 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.81958101 |
48 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.80815749 |
49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.76773439 |
50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76047309 |
51 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.75916683 |
52 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.75443582 |
53 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.72444722 |
54 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.71504761 |
55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.71107281 |
56 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.71056949 |
57 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.69837485 |
58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67816327 |
59 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.66302833 |
60 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.64695677 |
61 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.58490167 |
62 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.57173977 |
63 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.55461662 |
64 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.51460389 |
65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.51341123 |
66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.50967538 |
67 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50446557 |
68 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.50228458 |
69 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49451526 |
70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47073205 |
71 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45197856 |
72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44048101 |
73 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42691314 |
74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41823825 |
75 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.41390851 |
76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.40603987 |
77 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40419476 |
78 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.40076470 |
79 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39791996 |
80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39530441 |
81 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39475785 |
82 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.39444401 |
83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39384995 |
84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37947725 |
85 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.36614411 |
86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36587065 |
87 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.36464199 |
88 | MAF_26560356_Chip-Seq_TH1_Human | 1.36449868 |
89 | AR_19668381_ChIP-Seq_PC3_Human | 1.34952087 |
90 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.34512321 |
91 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.33482859 |
92 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33272660 |
93 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.32010194 |
94 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30302743 |
95 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.29446981 |
96 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27321513 |
97 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.25820389 |
98 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25664926 |
99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25476729 |
100 | TP53_16413492_ChIP-PET_HCT116_Human | 1.23945156 |
101 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21956674 |
102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21901200 |
103 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21628877 |
104 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21263016 |
105 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.20530670 |
106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19873942 |
107 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.19698358 |
108 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.19680482 |
109 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.17383361 |
110 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.16854538 |
111 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15184757 |
112 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14626322 |
113 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13707994 |
114 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.12730342 |
115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11989834 |
116 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11748812 |
117 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.11424249 |
118 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11141370 |
119 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.08275990 |
120 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.08275990 |
121 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07282504 |
122 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.06726272 |
123 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06676815 |
124 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06282749 |
125 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.06041039 |
126 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.05956195 |
127 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05810727 |
128 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05750606 |
129 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04411021 |
130 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.03042569 |
131 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.01773969 |
132 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01296683 |
133 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01260586 |
134 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.00058632 |
135 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00003357 |
136 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.99681920 |
137 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99203866 |
138 | P300_19829295_ChIP-Seq_ESCs_Human | 0.98908285 |
139 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98097430 |
140 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97683336 |
141 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97617965 |
142 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96710612 |
143 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96075728 |
144 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95590021 |
145 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95179693 |
146 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.94308865 |
147 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94140625 |
148 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94061001 |
149 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.93891292 |
150 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.93867796 |
151 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93521966 |
152 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92882199 |
153 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.92810345 |
154 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92232673 |
155 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92183059 |
156 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91719881 |
157 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91643489 |
158 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91410507 |
159 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90817397 |
160 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90485507 |
161 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89768091 |
162 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89453402 |
163 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89402561 |
164 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89331067 |
165 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.89188522 |
166 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.88641859 |
167 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.88300965 |
168 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.87814855 |
169 | UTX_26944678_Chip-Seq_JUKART_Human | 0.87639244 |
170 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.87390554 |
171 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.86603056 |
172 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85950949 |
173 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85895514 |
174 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85507045 |
175 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84451327 |
176 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83940584 |
177 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83900044 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 7.78063418 |
2 | MP0003880_abnormal_central_pattern | 4.51266059 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.50757205 |
4 | MP0004270_analgesia | 3.89948408 |
5 | MP0005451_abnormal_body_composition | 3.67413441 |
6 | * MP0002063_abnormal_learning/memory/cond | 3.59606990 |
7 | MP0009745_abnormal_behavioral_response | 3.48820311 |
8 | MP0002822_catalepsy | 3.46636727 |
9 | MP0003705_abnormal_hypodermis_morpholog | 3.43051123 |
10 | MP0002877_abnormal_melanocyte_morpholog | 3.11693018 |
11 | MP0002064_seizures | 3.10843521 |
12 | MP0005409_darkened_coat_color | 3.06528194 |
13 | MP0001968_abnormal_touch/_nociception | 2.84055821 |
14 | MP0003300_gastrointestinal_ulcer | 2.77365104 |
15 | MP0002572_abnormal_emotion/affect_behav | 2.77151824 |
16 | MP0003690_abnormal_glial_cell | 2.77058811 |
17 | MP0008260_abnormal_autophagy | 2.72696204 |
18 | MP0003656_abnormal_erythrocyte_physiolo | 2.70980192 |
19 | MP0009046_muscle_twitch | 2.66214952 |
20 | MP0009780_abnormal_chondrocyte_physiolo | 2.39440691 |
21 | MP0001486_abnormal_startle_reflex | 2.38899554 |
22 | MP0002734_abnormal_mechanical_nocicepti | 2.37805250 |
23 | MP0002272_abnormal_nervous_system | 2.32898097 |
24 | MP0005423_abnormal_somatic_nervous | 2.27315540 |
25 | MP0003303_peritoneal_inflammation | 2.22277116 |
26 | MP0003566_abnormal_cell_adhesion | 2.11796966 |
27 | MP0002909_abnormal_adrenal_gland | 2.07390212 |
28 | MP0010234_abnormal_vibrissa_follicle | 2.03154118 |
29 | MP0004811_abnormal_neuron_physiology | 2.02827668 |
30 | MP0003329_amyloid_beta_deposits | 2.02705448 |
31 | MP0002736_abnormal_nociception_after | 2.01760873 |
32 | MP0001501_abnormal_sleep_pattern | 2.01620065 |
33 | MP0004858_abnormal_nervous_system | 2.00319465 |
34 | MP0001440_abnormal_grooming_behavior | 1.97037083 |
35 | MP0002735_abnormal_chemical_nociception | 1.91328161 |
36 | MP0005464_abnormal_platelet_physiology | 1.88501126 |
37 | MP0000920_abnormal_myelination | 1.88459860 |
38 | MP0003191_abnormal_cellular_cholesterol | 1.88126816 |
39 | MP0002733_abnormal_thermal_nociception | 1.86650094 |
40 | MP0008569_lethality_at_weaning | 1.85808312 |
41 | MP0003091_abnormal_cell_migration | 1.84223227 |
42 | MP0004924_abnormal_behavior | 1.75471937 |
43 | MP0005386_behavior/neurological_phenoty | 1.75471937 |
44 | MP0001970_abnormal_pain_threshold | 1.74201670 |
45 | MP0010352_gastrointestinal_tract_polyps | 1.71954618 |
46 | MP0002067_abnormal_sensory_capabilities | 1.67984036 |
47 | MP0005058_abnormal_lysosome_morphology | 1.66032441 |
48 | MP0002184_abnormal_innervation | 1.64205552 |
49 | MP0002557_abnormal_social/conspecific_i | 1.64102439 |
50 | MP0000778_abnormal_nervous_system | 1.61168550 |
51 | MP0001958_emphysema | 1.60189026 |
52 | MP0003879_abnormal_hair_cell | 1.56819241 |
53 | MP0005076_abnormal_cell_differentiation | 1.55387758 |
54 | MP0002396_abnormal_hematopoietic_system | 1.55342974 |
55 | MP0002009_preneoplasia | 1.55082592 |
56 | MP0001915_intracranial_hemorrhage | 1.54986064 |
57 | MP0000955_abnormal_spinal_cord | 1.54746160 |
58 | MP0004808_abnormal_hematopoietic_stem | 1.52747633 |
59 | MP0003787_abnormal_imprinting | 1.49615551 |
60 | MP0004885_abnormal_endolymph | 1.48605263 |
61 | MP0008438_abnormal_cutaneous_collagen | 1.48276203 |
62 | MP0003436_decreased_susceptibility_to | 1.46223534 |
63 | MP0003828_pulmonary_edema | 1.46198674 |
64 | MP0000015_abnormal_ear_pigmentation | 1.43101992 |
65 | MP0000569_abnormal_digit_pigmentation | 1.40506779 |
66 | MP0003283_abnormal_digestive_organ | 1.38311097 |
67 | MP0002066_abnormal_motor_capabilities/c | 1.35422885 |
68 | MP0003633_abnormal_nervous_system | 1.35105452 |
69 | MP0004883_abnormal_blood_vessel | 1.33609891 |
70 | MP0002882_abnormal_neuron_morphology | 1.31634986 |
71 | MP0008961_abnormal_basal_metabolism | 1.30179394 |
72 | MP0008057_abnormal_DNA_replication | 1.29160150 |
73 | MP0005646_abnormal_pituitary_gland | 1.25340165 |
74 | MP0003724_increased_susceptibility_to | 1.24965018 |
75 | MP0004947_skin_inflammation | 1.20626590 |
76 | MP0001984_abnormal_olfaction | 1.19899195 |
77 | MP0004147_increased_porphyrin_level | 1.19251617 |
78 | MP0000678_abnormal_parathyroid_gland | 1.18417244 |
79 | MP0005621_abnormal_cell_physiology | 1.15292714 |
80 | * MP0002152_abnormal_brain_morphology | 1.14638006 |
81 | MP0001851_eye_inflammation | 1.12948712 |
82 | MP0003631_nervous_system_phenotype | 1.10879789 |
83 | MP0002419_abnormal_innate_immunity | 1.10674116 |
84 | MP0003075_altered_response_to | 1.09926720 |
85 | MP0003045_fibrosis | 1.08150843 |
86 | MP0003123_paternal_imprinting | 1.06953089 |
87 | MP0001529_abnormal_vocalization | 1.06786507 |
88 | MP0003453_abnormal_keratinocyte_physiol | 1.06718755 |
89 | MP0000013_abnormal_adipose_tissue | 1.04770941 |
90 | MP0000858_altered_metastatic_potential | 1.04360216 |
91 | MP0005187_abnormal_penis_morphology | 1.03155441 |
92 | MP0000751_myopathy | 1.02655119 |
93 | MP0008874_decreased_physiological_sensi | 1.01811818 |
94 | MP0008872_abnormal_physiological_respon | 0.99829720 |
95 | MP0005397_hematopoietic_system_phenotyp | 0.99477423 |
96 | MP0001545_abnormal_hematopoietic_system | 0.99477423 |
97 | MP0004185_abnormal_adipocyte_glucose | 0.98527873 |
98 | MP0003122_maternal_imprinting | 0.95871317 |
99 | MP0001502_abnormal_circadian_rhythm | 0.95406456 |
100 | MP0000604_amyloidosis | 0.94205166 |
101 | MP0004233_abnormal_muscle_weight | 0.92939795 |
102 | MP0001177_atelectasis | 0.92829858 |
103 | * MP0000703_abnormal_thymus_morphology | 0.91912484 |
104 | MP0002069_abnormal_eating/drinking_beha | 0.91447096 |
105 | MP0004510_myositis | 0.91202756 |
106 | MP0009278_abnormal_bone_marrow | 0.89866737 |
107 | MP0005623_abnormal_meninges_morphology | 0.87991833 |
108 | MP0005164_abnormal_response_to | 0.86999547 |
109 | MP0003763_abnormal_thymus_physiology | 0.86605337 |
110 | MP0005388_respiratory_system_phenotype | 0.85107195 |
111 | MP0002133_abnormal_respiratory_system | 0.85107195 |
112 | MP0010630_abnormal_cardiac_muscle | 0.84570748 |
113 | * MP0002398_abnormal_bone_marrow | 0.83864425 |
114 | MP0002132_abnormal_respiratory_system | 0.83171581 |
115 | MP0004145_abnormal_muscle_electrophysio | 0.80762665 |
116 | MP0004085_abnormal_heartbeat | 0.80725361 |
117 | MP0001188_hyperpigmentation | 0.78665532 |
118 | MP0002998_abnormal_bone_remodeling | 0.77892896 |
119 | MP0006276_abnormal_autonomic_nervous | 0.76243600 |
120 | MP0005384_cellular_phenotype | 0.75511193 |
121 | * MP0002086_abnormal_extraembryonic_tissu | 0.75352709 |
122 | MP0004215_abnormal_myocardial_fiber | 0.75063294 |
123 | MP0005174_abnormal_tail_pigmentation | 0.75063048 |
124 | MP0004484_altered_response_of | 0.74314459 |
125 | MP0005645_abnormal_hypothalamus_physiol | 0.74273071 |
126 | MP0005167_abnormal_blood-brain_barrier | 0.74057443 |
127 | MP0003632_abnormal_nervous_system | 0.73451601 |
128 | MP0010307_abnormal_tumor_latency | 0.71118984 |
129 | MP0001905_abnormal_dopamine_level | 0.69931075 |
130 | MP0006082_CNS_inflammation | 0.68579213 |
131 | MP0005535_abnormal_body_temperature | 0.68486067 |
132 | MP0002229_neurodegeneration | 0.67795913 |
133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66806076 |
134 | MP0002234_abnormal_pharynx_morphology | 0.66730602 |
135 | MP0001730_embryonic_growth_arrest | 0.66721439 |
136 | * MP0003861_abnormal_nervous_system | 0.66619572 |
137 | MP0000428_abnormal_craniofacial_morphol | 0.66593349 |
138 | MP0002971_abnormal_brown_adipose | 0.66233230 |
139 | MP0003183_abnormal_peptide_metabolism | 0.65591477 |
140 | MP0002090_abnormal_vision | 0.65086491 |
141 | MP0004142_abnormal_muscle_tone | 0.64875440 |
142 | MP0000631_abnormal_neuroendocrine_gland | 0.64863507 |
143 | MP0005166_decreased_susceptibility_to | 0.64773498 |
144 | MP0004264_abnormal_extraembryonic_tissu | 0.64721676 |
145 | MP0005023_abnormal_wound_healing | 0.64073418 |
146 | MP0001849_ear_inflammation | 0.63959390 |
147 | MP0003634_abnormal_glial_cell | 0.63847113 |
148 | * MP0002722_abnormal_immune_system | 0.63369556 |
149 | MP0003959_abnormal_lean_body | 0.62879371 |
150 | MP0004130_abnormal_muscle_cell | 0.62524312 |
151 | MP0004134_abnormal_chest_morphology | 0.60454342 |
152 | MP0000747_muscle_weakness | 0.60086190 |
153 | MP0003448_altered_tumor_morphology | 0.59319618 |
154 | MP0002089_abnormal_postnatal_growth/wei | 0.58751456 |
155 | MP0001835_abnormal_antigen_presentation | 0.58681907 |
156 | MP0005394_taste/olfaction_phenotype | 0.58665052 |
157 | MP0005499_abnormal_olfactory_system | 0.58665052 |
158 | MP0005025_abnormal_response_to | 0.58432266 |
159 | MP0003172_abnormal_lysosome_physiology | 0.58425225 |
160 | MP0010769_abnormal_survival | 0.56881730 |
161 | MP0001299_abnormal_eye_distance/ | 0.56852192 |
162 | MP0001348_abnormal_lacrimal_gland | 0.56059754 |
163 | MP0002837_dystrophic_cardiac_calcinosis | 0.55566101 |
164 | MP0001664_abnormal_digestion | 0.55091836 |
165 | MP0001943_abnormal_respiration | 0.54361441 |
166 | MP0003121_genomic_imprinting | 0.53988300 |
167 | MP0010768_mortality/aging | 0.52972836 |
168 | * MP0003956_abnormal_body_size | 0.52942609 |
169 | MP0010770_preweaning_lethality | 0.52504459 |
170 | MP0002082_postnatal_lethality | 0.52504459 |
171 | MP0008770_decreased_survivor_rate | 0.51836590 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.07943579 |
2 | Myokymia (HP:0002411) | 6.76300460 |
3 | Focal seizures (HP:0007359) | 5.49070639 |
4 | Visual hallucinations (HP:0002367) | 5.41199418 |
5 | Epileptic encephalopathy (HP:0200134) | 4.22537503 |
6 | Papilledema (HP:0001085) | 3.95504951 |
7 | Absence seizures (HP:0002121) | 3.85485837 |
8 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.78575312 |
9 | Atonic seizures (HP:0010819) | 3.76424326 |
10 | Poor eye contact (HP:0000817) | 3.71925168 |
11 | Action tremor (HP:0002345) | 3.64978265 |
12 | Progressive cerebellar ataxia (HP:0002073) | 3.54967471 |
13 | Depression (HP:0000716) | 3.48414152 |
14 | Dialeptic seizures (HP:0011146) | 3.46691068 |
15 | Abnormality of the lower motor neuron (HP:0002366) | 3.44155629 |
16 | Generalized tonic-clonic seizures (HP:0002069) | 3.43697200 |
17 | Abnormal social behavior (HP:0012433) | 3.37357685 |
18 | Impaired social interactions (HP:0000735) | 3.37357685 |
19 | Polycythemia (HP:0001901) | 3.35251669 |
20 | Febrile seizures (HP:0002373) | 3.33115445 |
21 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.27351485 |
22 | Ankle clonus (HP:0011448) | 3.23917160 |
23 | Broad-based gait (HP:0002136) | 3.21143494 |
24 | Urinary urgency (HP:0000012) | 3.19784219 |
25 | Supranuclear gaze palsy (HP:0000605) | 3.18012955 |
26 | Impaired smooth pursuit (HP:0007772) | 3.08041642 |
27 | Truncal ataxia (HP:0002078) | 3.04855806 |
28 | Dysdiadochokinesis (HP:0002075) | 2.99530052 |
29 | Postural instability (HP:0002172) | 2.96613390 |
30 | Abnormal gallbladder physiology (HP:0012438) | 2.95198275 |
31 | Cholecystitis (HP:0001082) | 2.95198275 |
32 | Eczematoid dermatitis (HP:0000976) | 2.94705976 |
33 | Annular pancreas (HP:0001734) | 2.92367820 |
34 | Gaze-evoked nystagmus (HP:0000640) | 2.92271894 |
35 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.86688688 |
36 | Dysmetric saccades (HP:0000641) | 2.86098351 |
37 | Dysmetria (HP:0001310) | 2.84185717 |
38 | Termporal pattern (HP:0011008) | 2.83162474 |
39 | Insidious onset (HP:0003587) | 2.83162474 |
40 | Amblyopia (HP:0000646) | 2.81686899 |
41 | Mutism (HP:0002300) | 2.75110216 |
42 | Anxiety (HP:0000739) | 2.73950406 |
43 | Drooling (HP:0002307) | 2.65669168 |
44 | Excessive salivation (HP:0003781) | 2.65669168 |
45 | Resting tremor (HP:0002322) | 2.63345807 |
46 | Genetic anticipation (HP:0003743) | 2.60880943 |
47 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.60568894 |
48 | Torticollis (HP:0000473) | 2.60236062 |
49 | * Bowel incontinence (HP:0002607) | 2.58171768 |
50 | Hyperventilation (HP:0002883) | 2.56333435 |
51 | * Pointed chin (HP:0000307) | 2.54669175 |
52 | Bradykinesia (HP:0002067) | 2.52889125 |
53 | Cerebral inclusion bodies (HP:0100314) | 2.52490361 |
54 | * Ankyloglossia (HP:0010296) | 2.51961484 |
55 | Hyperthyroidism (HP:0000836) | 2.50762948 |
56 | Megalencephaly (HP:0001355) | 2.46872579 |
57 | Amyotrophic lateral sclerosis (HP:0007354) | 2.46299796 |
58 | Focal dystonia (HP:0004373) | 2.45428763 |
59 | Scanning speech (HP:0002168) | 2.45326126 |
60 | Peripheral hypomyelination (HP:0007182) | 2.44764946 |
61 | Insomnia (HP:0100785) | 2.43794771 |
62 | * Stereotypic behavior (HP:0000733) | 2.42883329 |
63 | Abnormal eating behavior (HP:0100738) | 2.41752048 |
64 | Spastic gait (HP:0002064) | 2.41145235 |
65 | Decreased motor nerve conduction velocity (HP:0003431) | 2.39706387 |
66 | Intention tremor (HP:0002080) | 2.38799727 |
67 | Slow saccadic eye movements (HP:0000514) | 2.37953124 |
68 | * Abnormal large intestine physiology (HP:0012700) | 2.37662504 |
69 | Impaired vibratory sensation (HP:0002495) | 2.36810579 |
70 | Epileptiform EEG discharges (HP:0011182) | 2.35989094 |
71 | Abnormality of binocular vision (HP:0011514) | 2.34625132 |
72 | Diplopia (HP:0000651) | 2.34625132 |
73 | Reticulocytosis (HP:0001923) | 2.32830467 |
74 | Inappropriate behavior (HP:0000719) | 2.26806820 |
75 | Papillary thyroid carcinoma (HP:0002895) | 2.26296281 |
76 | EEG with generalized epileptiform discharges (HP:0011198) | 2.25811651 |
77 | Hemiplegia (HP:0002301) | 2.24913872 |
78 | Relative macrocephaly (HP:0004482) | 2.23588651 |
79 | Progressive inability to walk (HP:0002505) | 2.20041421 |
80 | Hypsarrhythmia (HP:0002521) | 2.17798202 |
81 | Ventricular fibrillation (HP:0001663) | 2.16409858 |
82 | Craniofacial dystonia (HP:0012179) | 2.15332903 |
83 | Apathy (HP:0000741) | 2.14445708 |
84 | Subacute progressive viral hepatitis (HP:0006572) | 2.14351529 |
85 | * Truncus arteriosus (HP:0001660) | 2.12947440 |
86 | Intellectual disability, profound (HP:0002187) | 2.12780344 |
87 | Deep palmar crease (HP:0006191) | 2.12458545 |
88 | Lower limb asymmetry (HP:0100559) | 2.11241903 |
89 | Lower limb amyotrophy (HP:0007210) | 2.09459585 |
90 | Spontaneous hematomas (HP:0007420) | 2.09286071 |
91 | Disproportionate tall stature (HP:0001519) | 2.09028435 |
92 | Status epilepticus (HP:0002133) | 2.06381342 |
93 | Lower limb muscle weakness (HP:0007340) | 2.05857521 |
94 | Abnormality of macrophages (HP:0004311) | 2.03605989 |
95 | Hemiparesis (HP:0001269) | 2.02925644 |
96 | Arterial tortuosity (HP:0005116) | 2.00704149 |
97 | Recurrent abscess formation (HP:0002722) | 2.00578998 |
98 | Gingivitis (HP:0000230) | 2.00553642 |
99 | * Abnormality of oral frenula (HP:0000190) | 1.99910595 |
100 | Recurrent bacterial skin infections (HP:0005406) | 1.98829367 |
101 | Absent speech (HP:0001344) | 1.97474279 |
102 | Clonus (HP:0002169) | 1.96894600 |
103 | Obstructive sleep apnea (HP:0002870) | 1.96069196 |
104 | Macroorchidism (HP:0000053) | 1.95883110 |
105 | Acute myeloid leukemia (HP:0004808) | 1.95446051 |
106 | Shoulder girdle muscle weakness (HP:0003547) | 1.94904238 |
107 | Cellulitis (HP:0100658) | 1.94904080 |
108 | Metaphyseal cupping (HP:0003021) | 1.94046105 |
109 | Diminished motivation (HP:0000745) | 1.93961158 |
110 | Achilles tendon contracture (HP:0001771) | 1.93686105 |
111 | Rapidly progressive (HP:0003678) | 1.92831149 |
112 | Abnormality of the corticospinal tract (HP:0002492) | 1.92768177 |
113 | Cerebral aneurysm (HP:0004944) | 1.91466498 |
114 | Hammertoe (HP:0001765) | 1.89101382 |
115 | Peritonitis (HP:0002586) | 1.89025823 |
116 | Bundle branch block (HP:0011710) | 1.88754693 |
117 | Neurofibrillary tangles (HP:0002185) | 1.87871150 |
118 | Gait ataxia (HP:0002066) | 1.87511381 |
119 | Vascular tortuosity (HP:0004948) | 1.86783682 |
120 | Heterotopia (HP:0002282) | 1.86709831 |
121 | Abnormality of the common coagulation pathway (HP:0010990) | 1.85293641 |
122 | Poikilocytosis (HP:0004447) | 1.85282946 |
123 | 11 pairs of ribs (HP:0000878) | 1.85091400 |
124 | Incomplete penetrance (HP:0003829) | 1.85021920 |
125 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.82378363 |
126 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81400207 |
127 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.80609810 |
128 | Abnormality of the fingertips (HP:0001211) | 1.79135455 |
129 | Foot dorsiflexor weakness (HP:0009027) | 1.79126727 |
130 | Onion bulb formation (HP:0003383) | 1.78503291 |
131 | Abnormality of saccadic eye movements (HP:0000570) | 1.78296831 |
132 | Prolonged bleeding time (HP:0003010) | 1.77693754 |
133 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.76889834 |
134 | Inability to walk (HP:0002540) | 1.75356950 |
135 | Generalized myoclonic seizures (HP:0002123) | 1.74787311 |
136 | Hypoventilation (HP:0002791) | 1.74678831 |
137 | Neuronal loss in central nervous system (HP:0002529) | 1.74651292 |
138 | Acanthocytosis (HP:0001927) | 1.74193323 |
139 | Fetal akinesia sequence (HP:0001989) | 1.72148705 |
140 | Abnormality of the astrocytes (HP:0100707) | 1.72043677 |
141 | Astrocytoma (HP:0009592) | 1.72043677 |
142 | * Dilatation of the ascending aorta (HP:0005111) | 1.71698579 |
143 | Chronic obstructive pulmonary disease (HP:0006510) | 1.71542260 |
144 | Obstructive lung disease (HP:0006536) | 1.71542260 |
145 | Orthostatic hypotension (HP:0001278) | 1.71256305 |
146 | Abnormality of the periventricular white matter (HP:0002518) | 1.71140683 |
147 | Dislocated radial head (HP:0003083) | 1.70335777 |
148 | Gingival bleeding (HP:0000225) | 1.69757298 |
149 | Agitation (HP:0000713) | 1.69622547 |
150 | Distal sensory impairment (HP:0002936) | 1.69372782 |
151 | Gastrointestinal infarctions (HP:0005244) | 1.68907180 |
152 | Increased connective tissue (HP:0009025) | 1.68254594 |
153 | Aqueductal stenosis (HP:0002410) | 1.68055201 |
154 | Rigidity (HP:0002063) | 1.68014040 |
155 | Protrusio acetabuli (HP:0003179) | 1.67706355 |
156 | Vertebral arch anomaly (HP:0008438) | 1.66575247 |
157 | Difficulty running (HP:0009046) | 1.65845832 |
158 | Atelectasis (HP:0100750) | 1.64529283 |
159 | Hypertensive crisis (HP:0100735) | 1.64097487 |
160 | Abnormality of the tricuspid valve (HP:0001702) | 1.63190674 |
161 | Patellar dislocation (HP:0002999) | 1.62593390 |
162 | Missing ribs (HP:0000921) | 1.60282821 |
163 | Tetraplegia (HP:0002445) | 1.60016502 |
164 | Hyperacusis (HP:0010780) | 1.59505588 |
165 | Overgrowth (HP:0001548) | 1.58056903 |
166 | Mitral regurgitation (HP:0001653) | 1.54101310 |
167 | Asymmetry of the thorax (HP:0001555) | 1.53706090 |
168 | Deep philtrum (HP:0002002) | 1.53349626 |
169 | Abnormality of the foot musculature (HP:0001436) | 1.52530999 |
170 | Distal upper limb amyotrophy (HP:0007149) | 1.52214412 |
171 | Upper limb amyotrophy (HP:0009129) | 1.52214412 |
172 | Viral hepatitis (HP:0006562) | 1.52092166 |
173 | Flat cornea (HP:0007720) | 1.50625936 |
174 | Abnormality of the radial head (HP:0003995) | 1.49551354 |
175 | Increased variability in muscle fiber diameter (HP:0003557) | 1.49458053 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 5.23399715 |
2 | MAP3K9 | 4.60363908 |
3 | * NTRK3 | 3.50806683 |
4 | MARK1 | 2.89666511 |
5 | MINK1 | 2.88456006 |
6 | DAPK2 | 2.88445580 |
7 | MAP3K4 | 2.74072048 |
8 | PAK6 | 2.47822678 |
9 | CDK12 | 2.42565161 |
10 | RIPK4 | 2.40852491 |
11 | PRKD3 | 2.32104000 |
12 | CAMKK1 | 2.24848909 |
13 | DAPK1 | 1.99965924 |
14 | ICK | 1.97132548 |
15 | FGFR3 | 1.93359448 |
16 | NTRK1 | 1.88988775 |
17 | MAP2K4 | 1.84660136 |
18 | MAP2K7 | 1.82552476 |
19 | WNK1 | 1.82433153 |
20 | NTRK2 | 1.77491867 |
21 | SCYL2 | 1.76039502 |
22 | MAP2K3 | 1.68013774 |
23 | MAP3K13 | 1.67842580 |
24 | FGFR4 | 1.61567543 |
25 | MAP3K12 | 1.61322207 |
26 | CDK5 | 1.59699674 |
27 | * KSR2 | 1.56781369 |
28 | SIK2 | 1.45407683 |
29 | ARAF | 1.44665106 |
30 | NEK1 | 1.44446548 |
31 | PLK2 | 1.39681773 |
32 | BLK | 1.38999394 |
33 | YES1 | 1.36925671 |
34 | CDK19 | 1.35968440 |
35 | TYRO3 | 1.34510829 |
36 | TAOK1 | 1.33475934 |
37 | EPHB1 | 1.30416850 |
38 | FES | 1.30181816 |
39 | STK38 | 1.29251262 |
40 | * KSR1 | 1.28046506 |
41 | TYK2 | 1.24027288 |
42 | ZAP70 | 1.22807053 |
43 | LATS2 | 1.22613027 |
44 | ERN1 | 1.21780517 |
45 | CAMKK2 | 1.18327493 |
46 | CLK1 | 1.17024785 |
47 | ALK | 1.15923636 |
48 | JAK1 | 1.13448679 |
49 | CSK | 1.11790332 |
50 | * JAK2 | 1.10235235 |
51 | PRKCG | 1.07961489 |
52 | PNCK | 1.06262066 |
53 | NEK6 | 1.04518767 |
54 | CDK14 | 1.00287003 |
55 | CDK18 | 0.99595800 |
56 | GRK5 | 0.99103114 |
57 | UHMK1 | 0.98996696 |
58 | CDK15 | 0.98385876 |
59 | PRKCH | 0.97869674 |
60 | EIF2AK1 | 0.96948777 |
61 | STK11 | 0.94760664 |
62 | RIPK1 | 0.93717507 |
63 | JAK3 | 0.91836040 |
64 | TRIB3 | 0.90784029 |
65 | PDK1 | 0.89265296 |
66 | CAMK1 | 0.88871715 |
67 | LMTK2 | 0.88377500 |
68 | PKN2 | 0.87292747 |
69 | PDGFRB | 0.87147686 |
70 | CDK11A | 0.86496186 |
71 | MAPK12 | 0.85824868 |
72 | TNIK | 0.84055019 |
73 | PTK2B | 0.83994861 |
74 | PAK3 | 0.83233409 |
75 | MAPK13 | 0.82916280 |
76 | TTN | 0.82041143 |
77 | PRPF4B | 0.81801686 |
78 | HCK | 0.80016521 |
79 | TRPM7 | 0.79998328 |
80 | * MAP3K1 | 0.78278847 |
81 | SMG1 | 0.77040406 |
82 | CAMK2A | 0.76589906 |
83 | PTK6 | 0.76328606 |
84 | PDPK1 | 0.74372580 |
85 | SGK3 | 0.70360266 |
86 | * RET | 0.70238904 |
87 | PHKG2 | 0.70037177 |
88 | PHKG1 | 0.70037177 |
89 | BRD4 | 0.69836685 |
90 | BRSK1 | 0.66734392 |
91 | PIK3CG | 0.65122668 |
92 | MAP3K7 | 0.64845546 |
93 | CSNK1G2 | 0.64534273 |
94 | MAP3K14 | 0.64270223 |
95 | MTOR | 0.63966746 |
96 | IRAK4 | 0.63036646 |
97 | * SGK1 | 0.62536565 |
98 | DMPK | 0.61918887 |
99 | BTK | 0.61737843 |
100 | SGK223 | 0.61151610 |
101 | SGK494 | 0.61151610 |
102 | SYK | 0.60840183 |
103 | MARK2 | 0.59803281 |
104 | IRAK2 | 0.59324948 |
105 | SGK2 | 0.58557298 |
106 | CAMK2B | 0.58037937 |
107 | NEK9 | 0.57325235 |
108 | CAMK1D | 0.56992261 |
109 | MAP3K10 | 0.54892597 |
110 | CDK6 | 0.54884765 |
111 | DYRK1A | 0.54156143 |
112 | RPS6KA3 | 0.54093266 |
113 | * MAP3K2 | 0.53740756 |
114 | CCNB1 | 0.53307099 |
115 | MAP3K3 | 0.52530563 |
116 | BMPR2 | 0.52287758 |
117 | FYN | 0.51775261 |
118 | LRRK2 | 0.50721041 |
119 | RPS6KB1 | 0.49080177 |
120 | PDGFRA | 0.47986743 |
121 | FER | 0.47352802 |
122 | MAPK10 | 0.46691026 |
123 | DAPK3 | 0.46069008 |
124 | PRKCZ | 0.45249531 |
125 | MAPK11 | 0.44983777 |
126 | CAMK1G | 0.42455193 |
127 | AKT3 | 0.42327514 |
128 | EEF2K | 0.41349885 |
129 | CDC42BPA | 0.37412962 |
130 | FGR | 0.35750154 |
131 | FGFR2 | 0.35736654 |
132 | CAMK4 | 0.35695891 |
133 | PRKCB | 0.34399874 |
134 | CSNK1E | 0.33535396 |
135 | MOS | 0.33232432 |
136 | MAP3K6 | 0.31256949 |
137 | RPS6KA2 | 0.29761758 |
138 | TNK2 | 0.28278785 |
139 | BMX | 0.27873458 |
140 | GRK6 | 0.27764115 |
141 | MAPK8 | 0.26470435 |
142 | FGFR1 | 0.25673250 |
143 | SRC | 0.25157416 |
144 | CASK | 0.24713883 |
145 | DDR2 | 0.24301741 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.13664361 |
2 | * Long-term potentiation_Homo sapiens_hsa04720 | 2.94478570 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.93634304 |
4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.82475843 |
5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.64944036 |
6 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.59694278 |
7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.58419165 |
8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.42460921 |
9 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.38428960 |
10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.37783334 |
11 | Morphine addiction_Homo sapiens_hsa05032 | 2.35632263 |
12 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.33495603 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.23537019 |
14 | Salivary secretion_Homo sapiens_hsa04970 | 2.16690484 |
15 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.01418560 |
16 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.95688915 |
17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.94227298 |
18 | Insulin secretion_Homo sapiens_hsa04911 | 1.91502176 |
19 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.88154306 |
20 | Renin secretion_Homo sapiens_hsa04924 | 1.83752052 |
21 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.78479282 |
22 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.72135888 |
23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.62118298 |
24 | * Long-term depression_Homo sapiens_hsa04730 | 1.58539447 |
25 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.58022240 |
26 | * Pancreatic cancer_Homo sapiens_hsa05212 | 1.53324610 |
27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.52951201 |
28 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.50895622 |
29 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.50431120 |
30 | * Glioma_Homo sapiens_hsa05214 | 1.46220063 |
31 | * Gap junction_Homo sapiens_hsa04540 | 1.45318251 |
32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.44413714 |
33 | Taste transduction_Homo sapiens_hsa04742 | 1.39122674 |
34 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.37152820 |
35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.36851507 |
36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.36077550 |
37 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29870342 |
38 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.29154724 |
39 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.27702073 |
40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27211696 |
41 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.26794226 |
42 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25594610 |
43 | * Oocyte meiosis_Homo sapiens_hsa04114 | 1.23493957 |
44 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.12414500 |
45 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10581850 |
46 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10151513 |
47 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.10048549 |
48 | * Melanogenesis_Homo sapiens_hsa04916 | 1.09664687 |
49 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08598531 |
50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08035936 |
51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03509173 |
52 | * Axon guidance_Homo sapiens_hsa04360 | 0.99381775 |
53 | Amoebiasis_Homo sapiens_hsa05146 | 0.98520346 |
54 | * Focal adhesion_Homo sapiens_hsa04510 | 0.94887335 |
55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94138766 |
56 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92476943 |
57 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92117499 |
58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92082508 |
59 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91843532 |
60 | * Hepatitis B_Homo sapiens_hsa05161 | 0.90297693 |
61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.90035102 |
62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.89484262 |
63 | * Leishmaniasis_Homo sapiens_hsa05140 | 0.88145949 |
64 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.86763183 |
65 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86421763 |
66 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85126768 |
67 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84484451 |
68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81570988 |
69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81472275 |
70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80621742 |
71 | * Adherens junction_Homo sapiens_hsa04520 | 0.79318724 |
72 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79247389 |
73 | * Tuberculosis_Homo sapiens_hsa05152 | 0.79242287 |
74 | * Prion diseases_Homo sapiens_hsa05020 | 0.79144083 |
75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78670273 |
76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.78367001 |
77 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78362511 |
78 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77912748 |
79 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77747617 |
80 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.76347328 |
81 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76178581 |
82 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75615922 |
83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.74872374 |
84 | * Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74236016 |
85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73562769 |
86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73562284 |
87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73361371 |
88 | * Prostate cancer_Homo sapiens_hsa05215 | 0.72940172 |
89 | * Alcoholism_Homo sapiens_hsa05034 | 0.70836901 |
90 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70682416 |
91 | Measles_Homo sapiens_hsa05162 | 0.68208482 |
92 | * Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.67213666 |
93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66525146 |
94 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66009538 |
95 | * Toxoplasmosis_Homo sapiens_hsa05145 | 0.65375585 |
96 | * Thyroid cancer_Homo sapiens_hsa05216 | 0.64045813 |
97 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.62959379 |
98 | Endocytosis_Homo sapiens_hsa04144 | 0.62466394 |
99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60413714 |
100 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60299625 |
101 | Insulin resistance_Homo sapiens_hsa04931 | 0.60022402 |
102 | Malaria_Homo sapiens_hsa05144 | 0.59893413 |
103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59175717 |
104 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.57263106 |
105 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57241285 |
106 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57067921 |
107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57055830 |
108 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55623193 |
109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55072355 |
110 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.52897036 |
111 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51865306 |
112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51207244 |
113 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48017212 |
114 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47548498 |
115 | * Colorectal cancer_Homo sapiens_hsa05210 | 0.46849173 |
116 | Bile secretion_Homo sapiens_hsa04976 | 0.46292721 |
117 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45959112 |
118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45099907 |
119 | * Platelet activation_Homo sapiens_hsa04611 | 0.43199288 |
120 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42342418 |
121 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41838204 |
122 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41141155 |
123 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41089142 |
124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39212587 |
125 | Phototransduction_Homo sapiens_hsa04744 | 0.36731455 |
126 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35193256 |
127 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35142371 |
128 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33246486 |
129 | Tight junction_Homo sapiens_hsa04530 | 0.33183020 |
130 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32952551 |
131 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31706233 |
132 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31101057 |